Screener
Design Therapeutics, Inc. DSGN Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026. Open the filing →
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
FAQ
- What is Design Therapeutics, Inc.'s enterprise value?
- Design Therapeutics, Inc. (DSGN) reported enterprise value of $646.16M in Q1 2026.
- How has Design Therapeutics, Inc.'s enterprise value changed year-over-year?
- Design Therapeutics, Inc.'s enterprise value increased by 211.3% year-over-year, from $207.58M to $646.16M.
- What is the long-term trend for Design Therapeutics, Inc.'s enterprise value?
- Over 4 years (2021 to 2025), Design Therapeutics, Inc.'s enterprise value has grown at a -12.7% compound annual growth rate (CAGR), from $893.48M to $519M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Design Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude